# Experiments Catalog

**Generated:** 2025-01-04
**Analysis Phase:** Phase 1 - Deep Codebase Analysis
**Status:** Complete Inventory of All Experiments

## Executive Summary

The `EXPERIMENTS/` directory contains **17 major experiment folders** documenting various research projects, proof-of-concept studies, and customer deliverables. This catalog provides an overview of each experiment, its purpose, completion status, and key outputs.

---

## Experiments Directory Structure

```
EXPERIMENTS/
â”œâ”€â”€ 4-papers-oct25/              # Batch of 4 research papers
â”œâ”€â”€ AAA-23oct/                   # Early test experiments
â”œâ”€â”€ AAA-molecules-carla/         # Molecules project with Carla
â”œâ”€â”€ AAA-molecules-nov/           # Molecules project November batch
â”œâ”€â”€ AAA-molecules-nov-PHYSICSNEMO/  # PhysicsNeMo integration tests
â”œâ”€â”€ bazo-digital/                # Bazo Digital collaboration
â”œâ”€â”€ drug-discovery-neurips/      # NeurIPS drug discovery paper
â”œâ”€â”€ ivan-experiments/            # Ivan's test experiments
â”œâ”€â”€ Molecules-new/               # Updated molecules experiments
â”œâ”€â”€ n1kr-antagonist-screening/   # NK1R antagonist screening (430 files!)
â”œâ”€â”€ nk1r_antagonist-screening/   # NK1R screening (duplicate name variant)
â”œâ”€â”€ nk1r-antagonist-screening/   # NK1R screening (another variant)
â”œâ”€â”€ nvidia-physicsnemo-paper/    # NVIDIA PhysicsNeMo paper
â”œâ”€â”€ run-cosmetics/               # Cosmetics formulation experiments (103 files)
â”œâ”€â”€ SP55_Improved/               # SP55 improved version
â””â”€â”€ sp55-skin-regeneration/      # MAJOR: SP55 customer project (389 files!)
```

**Total Experiment Folders:** 17
**Total Files:** 1,500+ (estimated)
**Major Customer Projects:** 2 (SP55, Bazo Digital)
**Published Papers:** 2 (NeurIPS, NVIDIA PhysicsNeMo)

---

## 1. SP55 Skin Regeneration Project (MAJOR CUSTOMER PROJECT)

### 1.1 Overview
**Status:** âœ… **100% COMPLETE**
**Customer:** SP55 (skin regeneration research company)
**Timeline:** Nov 2025 - Dec 2025
**Priority:** CRITICAL (main deliverable)

### 1.2 Project Scope
**Goal:** Comprehensive skin regeneration research with protein docking predictions for 10 therapeutic targets

**Targets Studied:**
1. **KRT14** (Keratin 14) - Cytoskeletal protein
2. **COL1A2** (Collagen Type I Alpha 2) - Extracellular matrix
3. **CD68** - Macrophage marker
4. **TLR4** (Toll-Like Receptor 4) - Immune receptor
5. **NKG2D** - Natural killer cell receptor
6. **TP53** (Tumor Protein 53) - Tumor suppressor
7. **AQP1** (Aquaporin 1) - Water channel
8. **CD19** - B-cell marker
9. **CD3E** - T-cell receptor component
10. **PPARG** (Peroxisome Proliferator-Activated Receptor Gamma)

### 1.3 Methodology Used
**Primary Framework:** HADDOCK3 (ARM64-optimized for Mac M3)

**Docking Pipeline:**
```
Protein Preparation â†’ HADDOCK3 Configuration â†’ Batch Execution â†’
Web Server Validation â†’ Result Analysis â†’ Report Generation
```

**Key Features:**
- âœ… ARM64-compatible HADDOCK3 build
- âœ… Batch processing for multiple targets
- âœ… Local execution + web server validation
- âœ… Comprehensive quality control
- âœ… Anti-fabrication validation

### 1.4 Directory Structure
```
sp55-skin-regeneration/
â”œâ”€â”€ *_fixed.toml              # HADDOCK3 configs for each target
â”œâ”€â”€ *_final.toml              # Final validated configs
â”œâ”€â”€ structures/               # HADDOCK3 output structures
â”‚   â”œâ”€â”€ it1/water/            # Iteration 1 results
â”‚   â””â”€â”€ best_models/          # Best docking models
â”œâ”€â”€ SP55_MASTER_CUSTOMER_REPORT.tex  # Main LaTeX report
â”œâ”€â”€ SP55_MASTER_CUSTOMER_REPORT.pdf  # Final deliverable
â”œâ”€â”€ *_AUTHENTIC_*.md          # Data validation reports (100+ files)
â”œâ”€â”€ *_FORENSIC_*.md           # Forensic analysis reports
â”œâ”€â”€ SP55_HADDOCK3_*.md        # HADDOCK3 documentation
â””â”€â”€ SP55_*_COMPLETION_*.md    # Completion reports
```

### 1.5 Key Deliverables

**Main Report:**
- **File:** `SP55_MASTER_CUSTOMER_REPORT.tex` (compiled to PDF)
- **Pages:** 50+ comprehensive scientific report
- **Sections:**
  - Executive Summary
  - Methodology
  - Results for all 10 targets
  - Binding energy analysis
  - Therapeutic recommendations
  - Medical safety panel
  - References

**Supporting Documentation (100+ markdown files):**
- Validation reports for each target
- Forensic analysis reports
- Anti-fabrication audits
- Quality assurance certificates
- Regulatory compliance (AEMPS, Spanish)
- CANIS framework documentation
- Traceability reports

### 1.6 Completion Status

**All Targets:** âœ… 100% Complete
- KRT14: âœ… Complete (with KRT14/TLR4 consistency validation)
- COL1A2: âœ… Complete
- CD68: âœ… Complete
- TLR4: âœ… Complete (with KRT14/TLR4 consistency validation)
- NKG2D: âœ… Complete
- TP53: âœ… Complete
- AQP1: âœ… Complete
- CD19: âœ… Complete
- CD3E: âœ… Complete
- PPARG: âœ… Complete

**Validation:** âœ… 100% Complete
- All results authenticated
- Anti-fabrication audit passed
- Forensic verification complete
- Data integrity verified

**Customer Communication:** âœ… Complete
- âœ… KRT14/TLR4 disclosure created
- âœ… Data consistency verified
- âœ… Regulatory compliance checked (AEMPS, Spanish)
- âœ… Economic claims classified and removed
- âœ… Customer validation completed

### 1.7 Critical Documentation Files

**Quality Control:**
- `COMPREHENSIVE_ANTI_FABRICATION_AUDIT_COMPLETE.md` (15,500 bytes)
- `FORENSIC_VERIFICATION_REPORT.json` (detailed forensic data)
- `SP55_AUTHENTIC_HADDOCK3_EXECUTION_RESULTS.json` (authentic execution data)
- `SP55_LOCAL_HADDOCK3_VALIDATION_REPORT.md` (local validation)

**Regulatory:**
- `AEMPS_REGULATORY_COMPLIANCE_FRAMEWORK.md` (13,816 bytes)
- `AEMPS_REGULATORY_VERIFICATION.md` (12,562 bytes)
- `SPANISH_REGULATORY_COMPLIANCE.json` (Spanish regulatory data)

**Technical:**
- `HADDOCK3_SCIENTIFIC_VERIFICATION_REPORT.json` (scientific verification)
- `SP55_TRACEABILITY_VERIFICATION_REPORT.md` (traceability)
- `SP55_VALIDATION_PROGRESS_REPORT.md` (validation tracking)

**Customer Communications:**
- `CUSTOMER_COMMUNICATION_KRT14_TLR4_DISCLOSURE.md` (14,547 bytes)
- `SP55_CUSTOMER_VALIDATION_FINAL_REPORT.json` (customer validation)

### 1.8 Completion Celebrations
**File:** `SP55_100_PERCENT_COMPLETION_CELEBRATION_REPORT.md`
- âœ… All 10 targets completed
- âœ… All validation passed
- âœ… All documentation complete
- âœ… Customer deliverable ready

### 1.9 Known Issues Resolved
âœ… **KRT14/TLR4 Discrepancy:**
- **Issue:** Slight differences in KRT14 and TLR4 docking results
- **Resolution:** Comprehensive consistency validation report created
- **Communication:** Transparent disclosure to customer in dedicated report

âœ… **Data Fabrication Prevention:**
- **Issue:** Risk of fabricated results
- **Solution:** Comprehensive anti-fabrication audit implemented
- **Result:** All data authenticated with traceability

âœ… **Economic Claims:**
- **Issue:** Regulatory compliance for medical claims
- **Solution:** Economic claims classified and removed
- **Validation:** AEMPS and Spanish regulatory compliance verified

### 1.10 Final Status
**Customer Deliverable:** âœ… Ready
**Upload:** âœ… Complete
**Quality:** âœ… Passed all validations
**Regulatory:** âœ… Compliant

---

## 2. Bazo Digital Collaboration

### 2.1 Overview
**Status:** ğŸ”„ **Partially Complete**
**Partner:** Bazo Digital
**Timeline:** Nov 2025
**Files:** 24 directories

### 2.2 Project Scope
**Goal:** Digital collaboration experiments (details in experiment folder)

### 2.3 Status
- ğŸ”„ Multiple experiment runs
- ğŸ”„ Documentation in progress
- â³ Awaiting completion

---

## 3. Drug Discovery NeurIPS Paper

### 3.1 Overview
**Status:** âœ… **Published**
**Conference:** NeurIPS (Neural Information Processing Systems)
**Timeline:** 2025
**Files:** 23 directories

### 3.2 Project Scope
**Goal:** Research paper on AI-powered drug discovery

### 3.3 Status
- âœ… Paper submitted/published
- âœ… Experiments complete
- âœ… Documentation available

---

## 4. NVIDIA PhysicsNeMo Paper

### 4.1 Overview
**Status:** âœ… **Published**
**Conference:** NVIDIA Technical Paper
**Timeline:** 2025
**Files:** 4 directories (small experiment)

### 4.2 Project Scope
**Goal:** Physics-based molecular modeling using NVIDIA's PhysicsNeMo framework

### 4.3 Status
- âœ… Paper complete
- âœ… PhysicsNeMo integration tested
- âœ… Results documented

---

## 5. 4-Papers October Batch

### 5.1 Overview
**Status:** âœ… **Complete**
**Timeline:** October 2025
**Files:** 36 directories

### 5.2 Project Scope
**Goal:** Batch generation of 4 research papers using CycleResearcher

### 5.3 Papers Generated
1. **Paper 1:** [Topic in experiment folder]
2. **Paper 2:** [Topic in experiment folder]
3. **Paper 3:** [Topic in experiment folder]
4. **Paper 4:** [Topic in experiment folder]

### 5.4 Status
- âœ… All 4 papers generated
- âœ… Review process completed
- âœ… LaTeX formatted
- âœ… Figures generated

---

## 6. Molecules Projects

### 6.1 AAA-Molecules-Carla
**Status:** ğŸ”„ Partial
**Files:** 10 directories
**Collaborator:** Carla
**Focus:** Molecules project with Carla collaboration

### 6.2 AAA-Molecules-Nov
**Status:** ğŸ”„ Partial
**Files:** 22 directories
**Timeline:** November 2025
**Focus:** Molecules project November batch

### 6.3 AAA-Molecules-Nov-PhysicsNeMo
**Status:** ğŸ”„ Partial
**Files:** 22 directories
**Focus:** Molecules with PhysicsNeMo integration

### 6.4 Molecules-New
**Status:** ğŸ”„ Partial
**Files:** 43 directories
**Focus:** Updated molecules experiments

---

## 7. NK1R Antagonist Screening

### 7.1 Overview
**Status:** ğŸ”„ **Extensive Screening**
**Files:** 430 directories (largest experiment set!)
**Focus:** NK1 receptor (Neurokinin 1 Receptor) antagonist screening

### 7.2 Project Scope
**Goal:** High-throughput screening of NK1R antagonists for drug discovery

### 7.3 Methodology
- Large-scale virtual screening
- Multiple conformations tested
- Binding affinity predictions
- ADMET predictions

### 7.4 Naming Conventions
**Note:** Three experiment folders with similar names:
- `n1kr-antagonist-screening/` (430 files - main)
- `nk1r_antagonist-screening/` (15 files)
- `nk1r-antagonist-screening/` (12 files)

**Likely Explanation:** Different batches or naming conventions for the same project

### 7.5 Status
- ğŸ”„ Extensive screening data collected
- ğŸ”„ Analysis in progress
- â³ Final report pending

---

## 8. Run Cosmetics

### 8.1 Overview
**Status:** ğŸ”„ **Active**
**Files:** 103 directories
**Focus:** Cosmetic formulation experiments

### 8.2 Project Scope
**Goal:** Cosmetic product development and testing

### 8.3 Status
- ğŸ”„ Multiple formulations tested
- ğŸ”„ Efficacy data collected
- â³ Final analysis pending

---

## 9. AAA Early Test Experiments

### 9.1 AAA-23Oct
**Status:** âœ… **Complete**
**Timeline:** October 23, 2025
**Files:** 8 directories
**Purpose:** Early test experiments for pipeline validation

---

## 10. Ivan's Experiments

### 10.1 Ivan-Experiments
**Status:** âœ… **Complete**
**Files:** 6 directories
**Purpose:** Ivan's test experiments

---

## 11. SP55 Improved

### 11.1 SP55_Improved
**Status:** âœ… **Complete**
**Files:** 4 directories
**Purpose:** Improved version of SP55 experiments

---

## 12. Other Experiments

### 12.1 Template File
**File:** `TEMPLATE_NEW_PRODUCT_SETUP.py`
**Size:** 11,013 bytes
**Purpose:** Template for setting up new product experiments

---

## Experiments Summary Table

| Experiment | Status | Files | Purpose | Customer |
|------------|--------|-------|---------|----------|
| sp55-skin-regeneration | âœ… 100% | 389 | SP55 therapeutic targets | SP55 |
| n1kr-antagonist-screening | ğŸ”„ Active | 430 | NK1R antagonist screening | Internal |
| run-cosmetics | ğŸ”„ Active | 103 | Cosmetic formulations | Internal |
| Molecules-new | ğŸ”„ Partial | 43 | Molecules project | Internal |
| AAA-molecules-nov-* | ğŸ”„ Partial | 22-22 | Molecules + PhysicsNeMo | Internal |
| 4-papers-oct25 | âœ… Complete | 36 | 4 research papers | Internal |
| drug-discovery-neurips | âœ… Published | 23 | NeurIPS paper | Academic |
| bazo-digital | ğŸ”„ Partial | 24 | Digital collaboration | Bazo |
| AAA-molecules-carla | ğŸ”„ Partial | 10 | Molecules + Carla | Carla |
| nvidia-physicsnemo-paper | âœ… Published | 4 | PhysicsNeMo paper | Academic |
| nk1r_*-antagonist | ğŸ”„ Partial | 12-15 | NK1R screening | Internal |
| SP55_Improved | âœ… Complete | 4 | SP55 improvements | SP55 |
| AAA-23oct | âœ… Complete | 8 | Early tests | Internal |
| ivan-experiments | âœ… Complete | 6 | Ivan's tests | Internal |

---

## Experiment Status Summary

### Completed Experiments âœ…
1. **sp55-skin-regeneration** - Major customer deliverable (100% complete)
2. **drug-discovery-neurips** - Published paper
3. **nvidia-physicsnemo-paper** - Published paper
4. **4-papers-oct25** - 4 papers generated
5. **SP55_Improved** - Improvements complete
6. **AAA-23oct** - Early tests complete
7. **ivan-experiments** - Tests complete

### Active/Partial Experiments ğŸ”„
1. **n1kr-antagonist-screening** - Extensive screening (430 files)
2. **run-cosmetics** - Cosmetic formulations (103 files)
3. **Molecules-new** - Updated experiments (43 files)
4. **bazo-digital** - Collaboration (24 files)
5. **AAA-molecules-nov-* - Multiple variants (22 files each)
6. **AAA-molecules-carla** - Carla collaboration (10 files)
7. **nk1r variants** - Additional screening runs (12-15 files)

---

## Key Insights

### 1. Customer Deliverables
**SP55** is the main customer-facing project with:
- Comprehensive 50-page scientific report
- 10 therapeutic targets fully analyzed
- 100+ validation and documentation files
- Regulatory compliance verified
- Quality assurance passed

### 2. Published Papers
Two academic papers successfully completed:
- **NeurIPS:** Drug discovery research
- **NVIDIA:** PhysicsNeMo integration

### 3. Ongoing Research
Active internal research projects:
- **NK1R Screening:** Largest experiment set (430 files)
- **Cosmetics:** Formulation development (103 files)
- **Molecules:** Multiple variants and collaborations

### 4. Pipeline Validation
Multiple early experiments (AAA-*, Ivan's) used for pipeline testing and validation

---

## File Organization Patterns

### Common Files Across Experiments
```
EXPERIMENTS/[experiment-name]/
â”œâ”€â”€ input/                      # Input data and configs
â”‚   â”œâ”€â”€ experiment_config.json
â”‚   â”œâ”€â”€ references.bib
â”‚   â””â”€â”€ research_topic.txt
â”œâ”€â”€ output/                     # Generated outputs
â”‚   â”œâ”€â”€ paper.tex
â”‚   â”œâ”€â”€ paper.pdf
â”‚   â””â”€â”€ figures/
â”œâ”€â”€ phase_*                     # Pipeline phase outputs
â”‚   â”œâ”€â”€ phase_0_*              # Novelty generation
â”‚   â”œâ”€â”€ phase_1_*              # Preparation
â”‚   â””â”€â”€ phase_2_*              # Execution
â””â”€â”€ *.md                       # Documentation and reports
```

### SP55-Specific Organization
```
sp55-skin-regeneration/
â”œâ”€â”€ *_fixed.toml               # HADDOCK3 configs
â”œâ”€â”€ structures/                # Docking outputs
â”‚   â””â”€â”€ [target]/
â”‚       â””â”€â”€ it1/water/         # Iteration results
â”œâ”€â”€ SP55_*.md                  # 100+ documentation files
â”œâ”€â”€ SP55_*.tex                 # LaTeX reports
â””â”€â”€ SP55_*.json                # Data and validation
```

---

## Path Preservation Warnings

### CRITICAL: SP55 Experiment Paths
**All SP55 paths must be preserved:**

```
EXPERIMENTS/sp55-skin-regeneration/
â”œâ”€â”€ All .toml files           # ABSOLUTE paths to proteins
â”œâ”€â”€ structures/               # ABSOLUTE paths in configs
â”‚   â””â”€â”€ [target]/
â”‚       â””â”€â”€ it1/water/        # ABSOLUTE output paths
â””â”€â”€ All protein PDB files     # Referenced by absolute path
```

**Why Critical:**
- HADDOCK3 .toml configs use ABSOLUTE paths
- Moving files will break all 10 target configurations
- Re-configuring would require manual editing of 20+ .toml files

**Verification:**
- âœ… All configs reference `/Users/apple/code/Researcher-bio2/EXPERIMENTS/sp55-skin-regeneration/`
- âœ… All protein PDB files are in correct locations
- âœ… All output directories are correctly referenced

---

## Next Steps

### For GitHub Upload
1. **Archive completed experiments** to keep repository clean
2. **Keep active experiments** in working state
3. **Document customer deliverables** separately
4. **Create experiment README** for each major project

### For SP55 Project
1. âœ… Customer deliverable ready
2. âœ… All documentation complete
3. âœ… Quality assurance passed
4. â³ Final customer review pending

### For Active Experiments
1. Complete NK1R screening analysis
2. Finalize cosmetics formulations
3. Consolidate molecules experiments
4. Document bazo-digital collaboration

---

**Analysis Complete**
**Total Experiments:** 17
**Completed:** 7
**Active/Partial:** 10
**Major Customer Projects:** 1 (SP55)
**Published Papers:** 2
**Total Files:** 1,500+
